Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Etoposide × Clear all

Sponsor

Conditions

Lymphoma 61 Lymphoma, Non-Hodgkin 44 Lymphoma, Large B-Cell, Diffuse 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Hodgkin Disease 38 Leukemia, Myeloid, Acute 36 Leukemia 34 Small Cell Lung Carcinoma 33 Burkitt Lymphoma 26 Lymphoma, Follicular 25 Lymphoma, Mantle-Cell 24 Lung Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Multiple Myeloma 15 Lymphoma, Large-Cell, Immunoblastic 15 Lymphoma, Large-Cell, Anaplastic 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Congenital Abnormalities 14 Recurrence 13 Lymphoma, B-Cell, Marginal Zone 13 Neuroblastoma 12 Neoplasms 12 Lymphoma, B-Cell 12 Myelodysplastic Syndromes 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Immunoblastic Lymphadenopathy 10 Sarcoma 9 Myeloproliferative Disorders 9 Lymphoma, T-Cell 9 Waldenstrom Macroglobulinemia 8

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡